White Rice and Effect of Gellan Gum on Glucose Responses by MRI (WIGG)

November 26, 2021 updated by: Luca Marciani, University of Nottingham

Effects of Gellan Gum on the Glycemic, Gastrointestinal and Appetitive Responses to a White Rice Meal Assessed by MRI

Rice is a staple food for over half the world's population. High consumption of white rice has been linked with high obesity and increased risk for type 2 diabetes. However, it is still the favoured type of rice among consumers, contributing to the observed increasing trends in diet-related diseases in countries with high rice consumption. Controlling the properties of white rice products (e.g. reducing the glycaemic index and/or increasing satiety) with relatively simple interventions could contribute to producing foods with health-promoting digestibility profiles.

One way to reduce the glycaemic index of white rice is through processing. Addition of food thickeners (called hydrocolloid gums) has previously been shown to reduce the digestibility of foods.

This work will test the hypothesis that gellan gum is a simple way to manipulate the body's glucose response to a white rice which in turn will have health-promoting effects. MRI imaging will be used to monitor the gastrointestinal responses.

Study Overview

Detailed Description

Addition of hydrocolloids has previously been shown to reduce the digestibility of foods. Hydrocolloids are polysaccharides used to increase viscosity and gelatinization and have many other applications in the food industry. However, there is a lack of mechanistic understanding on how these hydrocolloids may act during digestion in the human body. Preliminary in-house data suggested that the addition of gellan gum to rice cooking may reduce digestibility rates though mechanisms yet to be understood. This work will test the hypothesis that gellan gum can be used to manipulate white rice product properties to enhance health-promoting glycaemic, gastrointestinal and satiety responses in healthy human participants.

Aims:

1. to collect pilot data on postprandial glucose levels of isoenergetic test meal made from rice and Gellan Gum 2 . to collect data on their gastric emptying and satiety. 3. to compare postprandial glucose levels, gastric emptying and satiety for the treatments 4. to explore relationships between glucose levels, gastric emptying and satiety.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nottingham, United Kingdom, NG7 2UH
        • Nottingham Digestive Disases Centre , University of Nottingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Body mass index (BMI) ≥ 18.5 and ≤ 24.9 kg/m2
  • Able to give informed consent
  • Apparently healthy: no medical conditions or previous gastrointestinal surgery which might affect study measurements (judged by the investigators)

Exclusion Criteria:

  • Fasting fingerprick screening blood sugar level higher than 5.4 mmol/L
  • Restrained eating behaviour as determined by Eating habits and SCOFF screening questionnaires
  • Not used to eating breakfast
  • Not used to eating three meals a day
  • Use of medication which interferes with study measurements for example acid suppressants or anti-spasmodics.
  • Participation in another nutritional or biomedical trial 3 months before the pre-study screening or during the study.
  • Reported participation in night shift work during the two weeks prior to pre-study investigation or during the study. Night work is defined as working between midnight and 6.00 AM.
  • Strenuous exercise for more than10 hours per week.
  • Consumption of ≥21 alcoholic drinks in a typical week
  • Reported weight loss or gain ≥ 10 % of bodyweight during the six months period before the pre-study examination.
  • Following a medically- or self-prescribed diet during the two weeks prior to the pre-study examination and until the end of the study
  • Dislike of the products served as the dietary test treatments including the pasta meal
  • Any allergy or food intolerance to the test treatments
  • Not suitable for MRI scanning (e.g., presence of metal implants, infusion pumps and pacemakers) as assessed by standard MRI safety questionnaire.
  • Pregnancy or breastfeeding declared by candidate
  • Antibiotic or prescribed probiotic treatment in the past 12 weeks
  • Inability to lie flat
  • Poor understanding of the spoken and/or written English language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Gellan gum
White rice cooked with gellan gum
Jasmine rice 179g of cooked weight
Food grade hydrocolloid polysaccharide 5.5g dissolved in 356g cooking water containing 185g rice
Placebo Comparator: Control
White rice cooked without gellan gum
Jasmine rice 179g of cooked weight

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incremental Area Under the Curve of post prandial blood glucose up to 2h (iAUC2h)
Time Frame: 2 hours
Fingerprick blood glucose area under the curve for 2 hours
2 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ad libitum objective pasta meal at the end of the study day
Time Frame: 3 hours
Weighted amount of ad libitum pasta meal consumed at end of study morning
3 hours
Under the Curve for appetite scores post prandial up to 2 hours (AUC2h)
Time Frame: 2 hours
Area under the curve of Visual Analogue Scores up to 2 hours postprandially
2 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to Peak of blood glucose
Time Frame: 2 hours
Fingerprick blood glucose time to peak
2 hours
Peak blood glucose
Time Frame: 2 hours
Fingerprick blood glucose peak value
2 hours
Area Under the Curve of post prandial gastric volumes up to 2h (AUC2h)
Time Frame: 2 hours
Gastric volumes area under the curve from MRI images
2 hours
Visual appearance of meal in the stomach
Time Frame: 2 hours
Descriptive intragastric appearance (e.g. layering, boluses) of meal in the stomach
2 hours
Small bowel water content area under the curve (AUC2h)
Time Frame: 2 hours
Area under the curve of volume of freely mobile water in the small bowel from MRI images
2 hours
Explorative correlations
Time Frame: 2 hours
Explorative correlations between Fingerprick blood glucose area under the curve for 2 hours, Gastric volumes area under the curve from MRI images up to 2 hours postprandially and Area under the curve of appetite Visual Analogue Scores up to 2 hours postprandially
2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 14, 2021

Primary Completion (Actual)

October 27, 2021

Study Completion (Actual)

November 22, 2021

Study Registration Dates

First Submitted

August 11, 2021

First Submitted That Met QC Criteria

October 4, 2021

First Posted (Actual)

October 15, 2021

Study Record Updates

Last Update Posted (Actual)

November 29, 2021

Last Update Submitted That Met QC Criteria

November 26, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 470-2001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glycemic Response to Feeding in Healthy Participants

Clinical Trials on White rice

Subscribe